Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Tomonori Kobayakawa"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract We aimed to investigate the efficacy of romosozumab treatment compared with that of denosumab in especially male osteoporosis patients. This retrospective cohort study included 174 Japanese male patients receiving either denosumab or romosoz
Externí odkaz:
https://doaj.org/article/5ccca53c681c493c810eec19cca479f5
Autor:
Tomonori Kobayakawa, Akiko Miyazaki, Makoto Saito, Takako Suzuki, Jun Takahashi, Yukio Nakamura
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Denosumab and romosozumab, a recently approved new drug, are effective and widely known molecular-targeted drugs for postmenopausal osteoporosis treatment. However, no studies have directly compared their therapeutic effects or safety in pos
Externí odkaz:
https://doaj.org/article/1b85915e4614449ba0b1d9cc85b515ff
Autor:
Nobunori Takahashi, Shuji Asai, Tomonori Kobayakawa, Atsushi Kaneko, Tatsuo Watanabe, Takefumi Kato, Tsuyoshi Nishiume, Hisato Ishikawa, Yutaka Yoshioka, Yasuhide Kanayama, Tsuyoshi Watanabe, Yuji Hirano, Masahiro Hanabayashi, Yuichiro Yabe, Yutaka Yokota, Mochihito Suzuki, Yasumori Sobue, Kenya Terabe, Naoki Ishiguro, Toshihisa Kojima
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
Abstract This study aimed to evaluate the short-term effectiveness and safety profiles of baricitinib and explore factors associated with improved short-term effectiveness in patients with rheumatoid arthritis (RA) in clinical settings. A total of 11
Externí odkaz:
https://doaj.org/article/cefd54fdc5a84f4fa82fa7059156b450
Autor:
Tomonori Kobayakawa, Takako Suzuki, Masaki Nakano, Makoto Saito, Akiko Miyazaki, Jun Takahashi, Yukio Nakamura
Publikováno v:
Bone Reports, Vol 14, Iss , Pp 101068- (2021)
Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such conditions as osteoporosis. The purpose of this study was to investigate the
Externí odkaz:
https://doaj.org/article/13363401999b4080bb542ee3cecd459c
Autor:
Masatoshi Hayashi, Hiroshi Kuraishi, Takeshi Masubuchi, Kaneyuki Furihata, Yuka Aida, Tomonori Kobayakawa, Masao Deguchi, Toshihisa Kojima, Naoki Ishiguro, Toshihisa Kanamono
Publikováno v:
Clinical Medicine Insights: Case Reports, Vol 2013, Iss 6, Pp 101-106 (2013)
Externí odkaz:
https://doaj.org/article/19b5294fab114869934048593b6e1eda
Autor:
Masatoshi Hayashi, Hiroshi Kuraishi, Takeshi Masubuchi, Kaneyuki Furihata, Yuka Aida, Tomonori Kobayakawa, Masao Deguchi, Toshihisa Kojima, Naoki Ishiguro, Toshihisa Kanamono
Publikováno v:
Clinical Medicine Insights: Case Reports, Vol 6 (2013)
We present a rare fatal case of relapsing pneumonia caused by Legionella pneumophila in a patient with rheumatoid arthritis after only two injections of adalimumab. A 78-year-old Japanese woman with a 14-year history of rheumatoid arthritis was presc
Externí odkaz:
https://doaj.org/article/9464867e607142c89b97ddb58e179c5e
Autor:
Tomonori Kobayakawa, Akiko Miyazaki, Yasuhide Kanayama, Yuji Hirano, Jun Takahashi, Takako Suzuki, Yukio Nakamura
Publikováno v:
Modern Rheumatology. 33:96-103
Objectives Romosozumab is a newly released and widely known molecular-targeted drug for severe osteoporosis treatment with comparable effectiveness to denosumab. However, there have been no reports discussing the efficacy of those treatments for rheu
Autor:
Yutaka Yoshioka, Masatoshi Hayashi, Mochihito Suzuki, Naoki Ishiguro, Yosuke Hattori, Takuya Matsumoto, Takefumi Kato, Yachiyo Kuwatsuka, Yasuhide Kanayama, Tsuyoshi Nishiume, Hisato Ishikawa, Tomone Shioura, Toki Takemoto, Tomonori Kobayakawa, Yuji Hirano, Shuji Asai, Nobuyuki Asai, Masahiko Ando, Yuichiro Yabe, Masahiro Hanabayashi, Yasumori Sobue, Toshihisa Kojima, Takayoshi Fujibayashi, Nobunori Takahashi
Publikováno v:
Revue du Rhumatisme. 88:354-361
Resume Objectif Etudier les facteurs predictifs de poussee de polyarthrite rhumatoide (PR) apres arret du methotrexate chez des patients japonais presentant une faible activite stable de la maladie sous traitement combine de tocilizumab (TCZ) et meth
Autor:
Takako Suzuki, Jun Takahashi, Makoto Saito, Tomonori Kobayakawa, Yukio Nakamura, Akiko Miyazaki
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Scientific Reports
Scientific Reports
Denosumab and romosozumab, a recently approved new drug, are effective and widely known molecular-targeted drugs for postmenopausal osteoporosis treatment. However, no studies have directly compared their therapeutic effects or safety in postmenopaus
Autor:
Mochihito Suzuki, Kenya Terabe, Tsuyoshi Watanabe, Yasuhide Kanayama, Tatsuo Watanabe, Masahiro Hanabayashi, Naoki Ishiguro, Yutaka Yoshioka, Atsushi Kaneko, Yuji Hirano, Shuji Asai, Tomonori Kobayakawa, Hisato Ishikawa, Yuichiro Yabe, Toshihisa Kojima, Takefumi Kato, Yutaka Yokota, Tsuyoshi Nishiume, Yasumori Sobue, Nobunori Takahashi
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
Scientific Reports
Scientific Reports
This study aimed to evaluate the short-term effectiveness and safety profiles of baricitinib and explore factors associated with improved short-term effectiveness in patients with rheumatoid arthritis (RA) in clinical settings. A total of 113 consecu